Bioneer Corp. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
2,209
2,395
8,252
4,886
9,295
Total Accounts Receivable
16,585
13,094
12,515
7,961
6,651
Inventories
8,771
9,506
9,321
7,852
8,910
Other Current Assets
1,604
1,925
2,118
2,373
2,254
Total Current Assets
29,169
26,921
32,205
23,072
27,110
Net Property, Plant & Equipment
21,632
20,127
18,860
19,752
19,470
Total Investments and Advances
467
1,001
672
750
801
Long-Term Note Receivable
578
215
251
154
203
Intangible Assets
17,606
19,096
19,998
19,789
16,202
Other Assets
483
-
-
194
160
Total Assets
69,934
67,360
71,985
81,802
63,945
ST Debt & Current Portion LT Debt
28,145
25,978
25,084
19,441
13,636
Accounts Payable
2,450
1,459
1,424
2,192
1,535
Other Current Liabilities
3,722
3,800
4,302
4,452
5,032
Total Current Liabilities
34,318
31,237
30,810
26,086
20,203
Long-Term Debt
1,600
1,430
650
5,450
5,244
Provision for Risks & Charges
2,516
3,189
3,596
3,664
3,434
Deferred Taxes
1,460
1,572
1,572
1,927
2,095
Other Liabilities
504
760
826
468
573
Total Liabilities
40,397
38,187
37,454
55,687
31,550
Common Equity (Total)
29,537
29,172
34,531
26,115
32,396
Total Shareholders' Equity
29,537
29,172
34,531
26,115
32,396
Total Equity
29,537
29,172
34,531
26,115
32,396
Liabilities & Shareholders' Equity
69,934
67,360
71,985
81,802
63,945

About Bioneer

View Profile
Address
8-11 Munpyeongseo-ro
Daejeon DE 34302
Korea, Republic Of
Employees -
Website http://www.bioneer.co.kr
Updated 09/14/2018
BIONEER Corp. engages in the manufacture and sale of biotechnological products. Its products include gene reagent, molecular diagnosis kit, and supply and equipment for biological research. The company was founded on August 28, 1992 and is headquartered in Daejeon, South Korea.